GPD2: The relationship with cancer and neural stemness

Maimaiti Mikeli1, Makoto Fujikawa2, Tsutomu Tanabe1

  • 1Department of Pharmacology and Neurobiology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Cells & Development
|January 2, 2023
PubMed

Insights

Knocking down glycerol-3-phosphate dehydrogenase 2 (GPD2) reduces cancer stemness in liver and neuroblastoma cells. GPD2 may maintain both cancer and neural stem cells, offering a potential therapeutic target.

Area of Science:

  • Biochemistry
  • Cancer Biology
  • Stem Cell Research

Background:

  • Glycerol-3-phosphate dehydrogenase 2 (GPD2) is crucial for the glycerol-phosphate shuttle.
  • Previous studies linked GPD2 knockdown to reduced cancer stemness in hepatocarcinoma cells.

Purpose of the Study:

  • To investigate the role of GPD2 in maintaining cancer stemness in other cell lines.
  • To explore GPD2's potential involvement in neural stem cell maintenance.

Main Methods:

  • Knockdown of GPD2 in human hepatocarcinoma (HuH-7) and neuroblastoma (SH-SY5Y) cell lines.
  • Assessment of sphere formation ability to evaluate cancer stemness.
  • Analysis of morphological changes and expression of neuronal marker genes (GAP43, NeuN, TUBB3) in SH-SY5Y cells.

Main Results:

  • GPD2 knockdown reduced sphere formation in both HuH-7 and SH-SY5Y cells, indicating decreased cancer stemness.
  • Knocking down GPD2 in SH-SY5Y cells induced morphological changes and increased expression of neuronal markers.
  • These findings suggest GPD2 is involved in maintaining both cancer and neural stemness.

Conclusions:

  • GPD2 plays a role in the common mechanism for maintaining cancer stem cells.
  • GPD2 may also contribute to neural stem cell maintenance.
  • GPD2 represents a potential novel target for cancer therapy and stem cell research.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
3.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K